Oruka Therapeutics, Inc.
ORKA
$10.45
$0.171.65%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -33.39M | -28.62M | -22.24M | -7.08M | |
| Total Depreciation and Amortization | 18.50K | 11.00K | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 4.26M | 10.53M | 689.00K | 86.00K | |
| Change in Net Operating Assets | 5.03M | -9.73M | 10.52M | 6.82M | |
| Cash from Operations | -24.08M | -27.82M | -11.03M | -168.00K | |
| Capital Expenditure | -35.20K | -171.00K | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -359.93M | -- | -- | -- | |
| Cash from Investing | -359.97M | -171.00K | -- | -- | |
| Total Debt Issued | -414.94M | 417.21M | 0.00 | 24.98M | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 454.57M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | 266.50K | 0.00 | 0.00 | 2.93M | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 449.10K | 6.53M | -1.59M | -- | |
| Cash from Financing | 40.34M | 423.74M | -1.59M | 27.91M | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -343.70M | 395.75M | -12.62M | 27.74M | |